LCDR - Leukemia Clinical Data Repository Lab
  • HOME
  • WORK
  • TEAM
  • PUBLICATIONS
  • SUPPORT
  • LOGIN
  • CONTACT

HMDR Work

HMDR Research

Integration of highly curated clinical, pathologic, and genetic data is a central challenge in translational research. We developed the Hematologic Malignancy Data Repository (HMDR) as a way to enhance the scope and uniformity of clinical data and promote clinical and translational research in hematologic malignancies as DFCI.
  • Systemic abstraction of high-quality clinical, and genetic data: we defined a set of core clinical, and genetic data elements for all patients, augmented by additional disease specific data elements.
  • Enable access to integrated, de-identified data: to facilitate hypothesis generation, study design, and feasibility assessment, these curated data are made available to investigators through cBioPortal in collaboration with the Knowledge Systems Group.
  • Facilitate access to data and promote conduct of research: the HMDR Lab is a research support team that provides a step-by-step data request pipeline which guides users through cohort generation, governance, IRB application, and data delivery. 

 HOME | RESEARCH | PEOPLE  | PUBLICATIONS | SUPPORT  | CONTACT

©2019 LCDR Lab at Dana-Farber Cancer Institute
  • HOME
  • WORK
  • TEAM
  • PUBLICATIONS
  • SUPPORT
  • LOGIN
  • CONTACT